BSECompany Update26 Aug 2026 · 26 Aug 2026, 02:03 pm
The Exchange has sought clarification from GlaxoSmithKline Pharmaceuticals Ltd on August 26, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.
GlaxoSmithKline Pharmaceuticals Ltd · 500660
✦ AI SummaryRegulatory
GlaxoSmithKline Pharmaceuticals Ltd has received a clarification request from the exchange regarding a sudden movement in trading volume on August 26, 2026. The company is expected to respond to the query.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Clarification sought from GlaxoSmithKline Pharmaceuticals Ltd